iBio (IBIO) Other Operating Expenses (2013 - 2024)
iBio's (IBIO) quarterly Other Operating Expenses came in at $1.0 million in Q1 2024, up 158.62% on a QoQ basis from -$1.7 million in Q2 2023.
iBio (IBIO) Other Operating Expenses (2013 - 2024) Analysis & Trends
iBio (IBIO) has 10 years of Other Operating Expenses data on file, last reported at $1.0 million in Q1 2024.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $1.0 million in Q1 2024; TTM through Dec 2024 was $1.0 million, a 158.62% increase from a year earlier, with the FY2024 full-year figure at $1.0 million, changed N/A from the prior year.
- Other Operating Expenses for Q1 2024 stood at $1.0 million, up from -$1.7 million in the prior quarter.
- Over the last five years, Other Operating Expenses for IBIO reached as high as $5.7 million in Q4 2022 and fell as low as -$1.7 million in Q2 2023.
- Historically, Other Operating Expenses has averaged $596750.0 across 5 years, with a median of -$182500.0 in 2020.
- Across the five-year window, Other Operating Expenses jumped 9385.25% in 2022 and plunged 147.89% in 2023, its largest moves.
- Year by year, Other Operating Expenses stood at -$177000.0 in 2020, then surged by 65.54% to -$61000.0 in 2021, then soared by 9385.25% to $5.7 million in 2022, then plunged by 130.12% to -$1.7 million in 2023, then surged by 158.62% to $1.0 million in 2024.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $1.0 million in Q1 2024, -$1.7 million in Q2 2023, and $5.7 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn |
| 10 | iBio | 166.84 Mn | 166.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.00 Mn |
| Jun 30, 2023 | -1.71 Mn |
| Dec 31, 2022 | 5.66 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Dec 31, 2021 | -61,000.00 |
| Sep 30, 2021 | -189,000.00 |
| Jun 30, 2021 | -193,000.00 |
| Mar 31, 2021 | -189,000.00 |
| Dec 31, 2020 | -177,000.00 |
| Sep 30, 2020 | -185,000.00 |
| Jun 30, 2020 | -185,000.00 |
| Mar 31, 2020 | -180,000.00 |
| Dec 31, 2019 | -165,000.00 |
| Sep 30, 2019 | -171,000.00 |
| Jun 30, 2019 | -259,000.00 |
| Mar 31, 2019 | -265,000.00 |
| Dec 31, 2018 | -304,000.00 |
| Sep 30, 2018 | -238,000.00 |
| Jun 30, 2017 | 3.27 Mn |
| Mar 31, 2014 | 3,000.00 |